Inhaled Sedation in Critically Ill Patients
Phase 4
Not yet recruiting
- Conditions
- SedationAirway Extubation
- Interventions
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-05
- Target Recruit Count
- 620
- Registration Number
- NCT07000526
- Locations
- 🇪🇸
Hospital Vega Baja, Orihuela, Alicante, Spain
🇪🇸Hospital Universitario Doctor José Molina Orosa, Arrecife, Lanzarote-Canary Islands, Spain
🇪🇸Hospital Universitario de Albacete, Albacete, Spain
Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Phase 1
Recruiting
- Conditions
- Infant, Premature, DiseasesCirculatory and Respiratory Physiological Phenomena
- Interventions
- Drug: Intravenous dobutamine 5 mcg/kg/minDrug: Intravenous dobutamine 7.5 mcg/kg/minDrug: Intravenous dobutamine 10 mcg/kg/minDrug: Intravenous dobutamine 12.5 mcg/kg/minDrug: Intravenous dobutamine 15 mcg/kg/min
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Target Recruit Count
- 30
- Registration Number
- NCT06878742
- Locations
- 🇪🇸
Hospital Universitario Quironsalud, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
🇪🇸Hospital Universitario La Paz, Madrid, Spain
Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults
Phase 1
Not yet recruiting
- Conditions
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Interventions
- Biological: Autologous CD19/CD22 CAR T cellsBiological: Allogeneic CART-NKG2D cells
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Target Recruit Count
- 10
- Registration Number
- NCT06709469
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Phase 4
Not yet recruiting
- Conditions
- Kidney Disease, ChronicTransplant Recipient (Kidney)Immunosuppression
- Interventions
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-12-03
- Target Recruit Count
- 160
- Registration Number
- NCT06701825
- Locations
- 🇪🇸
Hospital La Paz, Madrid, Comunidad De Madrid, Spain
A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.
Phase 4
Not yet recruiting
- Conditions
- Botulinum Toxin Type AClinical TrialAbdominal WallOpen Abdomen
- Interventions
- Other: CONTROL
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Target Recruit Count
- 50
- Registration Number
- NCT06556030
Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts
Phase 2
Recruiting
- Conditions
- Aortic Aneurysm, Abdominal
- Interventions
- Drug: Allogeneic adipose tissue-derived mesenchymal stem cells
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-08
- Target Recruit Count
- 8
- Registration Number
- NCT06488898
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models
Phase 4
Recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Second-line systemic treatmentOther: Folllow-up of second-line systemic treatment already started
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Target Recruit Count
- 150
- Registration Number
- NCT06366932
- Locations
- 🇪🇸
Hospital La Paz, Madrid, Spain
Assessing Interest in Web/App Platforms for Early Phase Clinical Trial Recruitment
Not yet recruiting
- Conditions
- Assessing Interest in a Platform for Early Phase Clinical Trial Recruitment
- Interventions
- Other: Questionnaires
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-03-15
- Target Recruit Count
- 100
- Registration Number
- NCT06302647
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
Not Applicable
Not yet recruiting
- Conditions
- eHealthArthritis, RheumatoidTelemedicineTelehealthRheumatic DiseasesSpondylarthritis
- Interventions
- Device: IMIDOC
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2024-02-22
- Target Recruit Count
- 360
- Registration Number
- NCT06273306
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Phase 4
Not yet recruiting
- Conditions
- Cardiovascular DiseasesDyslipidemiasPharmacogenic MyopathyStatin Adverse Reaction
- Interventions
- Other: Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelinesOther: Standard of Care (SoC) dosing of atorvastatinOther: Standard of Care (SoC) dosing of simvastatinOther: Preemptive pharmacogenetic simvastatin dose based on CPIC guidelinesOther: Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelinesOther: Standard of Care (SoC) dosing of pitavastatinOther: Standard of Care (SoC) dosing of rosuvastatinOther: Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelinesOther: Preemptive pharmacogenetic pravastatin dose based on CPIC guidelinesOther: Standard of Care (SoC) dosing of prasavastatinOther: Standard of Care (SoC) dosing of lovastatinOther: Preemptive pharmacogenetic lovastatin dose based on CPIC guidelinesOther: Standard of Care (SoC) dosing of fluvastatinOther: Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2024-02-16
- Target Recruit Count
- 216
- Registration Number
- NCT06262685
- Locations
- 🇪🇸
Hospital La Paz, Madrid, Comunidad De Madrid, Spain